Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Tepezza (teprotumumab) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Covered by Blue Cross Blue Shield in Washington Fastest path: Submit prior authorization with complete TED documentation (CAS score, photos, euthyroid labs, ophthalmologist prescription). If denied, file internal appeal within plan deadlines, then request IRO external review through Washington's Office of Insurance Commissioner (1-800-562-6900)
6 min read

How to Get Entresto (sacubitril/valsartan) Covered by Blue Cross Blue Shield in Florida: Complete Forms, Appeals & Contact Guide

Answer Box: Getting Entresto Covered by Florida Blue Cross Blue Shield Entresto (sacubitril/valsartan) requires prior authorization from Florida Blue Cross Blue Shield in 2024. Your doctor must submit a PA request form showing you meet clinical criteria—typically heart failure with reduced ejection fraction and documented failure/intolerance to
7 min read

How to Get Ibrance (Palbociclib) Covered by Blue Cross Blue Shield in Florida: Complete PA Guide & Appeal Scripts

Answer Box: Getting Ibrance Covered by Florida Blue Cross Blue Shield Quick Path to Approval: Florida Blue requires prior authorization for Ibrance (palbociclib) in HR+/HER2- metastatic breast cancer. Submit documentation showing hormone receptor-positive status, staging, and combination therapy plan (with aromatase inhibitor or fulvestrant). If denied, you have 180
7 min read

How Long Does It Take to Get Uptravi (Selexipag) Approved by Blue Cross Blue Shield in Georgia? Timeline & Milestones

Answer Box: Uptravi Approval Timeline in Georgia Blue Cross Blue Shield Georgia typically processes Uptravi (selexipag) prior authorization requests within 5-7 business days for standard reviews, or 72 hours for expedited cases. Success depends on complete documentation of WHO Group I PAH diagnosis, background therapy failures, and specialist prescriber credentials.
6 min read